Clinical Trials Directory

Genomic Analysis of Pediatric Bone Tumors (Other Title: Pediatric Bone Tumor Biology Study)

To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).

Stanford is now accepting new patients for this trial. Please contact Lolita Penland at 650-736-2753 for more information.

Investigator(s):

Phase: N/A

Eligibility

Ages Eligible For Study:

N/A - 18 Years

Inclusion Criteria

All patients with bone x-rays suggestive of a malignant bone tumor

External Links

Explore related trials

Contact information

Primary Contact:

Lolita Penland 650-736-2753

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: